Viewing Study NCT04197492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:55 PM
Ignite Modification Date: 2026-01-20 @ 7:05 AM
Study NCT ID: NCT04197492
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-05
First Post: 2019-12-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas
Sponsor: Huashan Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypofractionated Stereotactic Radiotherapy View
None Recurrent High-grade Glioma View
None Anlotinib View